ATE478683T1 - Teilchenförmiges adjuvans für hifu-therapie und seine verwendung - Google Patents

Teilchenförmiges adjuvans für hifu-therapie und seine verwendung

Info

Publication number
ATE478683T1
ATE478683T1 AT05781870T AT05781870T ATE478683T1 AT E478683 T1 ATE478683 T1 AT E478683T1 AT 05781870 T AT05781870 T AT 05781870T AT 05781870 T AT05781870 T AT 05781870T AT E478683 T1 ATE478683 T1 AT E478683T1
Authority
AT
Austria
Prior art keywords
enhancement agent
hifu treatment
particle
treatment
hifu
Prior art date
Application number
AT05781870T
Other languages
English (en)
Inventor
Zhibiao Wang
Faqi Li
Yanbing Xiao
Ziwen Xiao
Liping Liu
Zhilong Wang
Original Assignee
Chongqing Haifu Hifu Tech Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Haifu Hifu Tech Co filed Critical Chongqing Haifu Hifu Tech Co
Application granted granted Critical
Publication of ATE478683T1 publication Critical patent/ATE478683T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A61K41/0033—Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic effects enhanced through application of ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
AT05781870T 2005-01-10 2005-09-02 Teilchenförmiges adjuvans für hifu-therapie und seine verwendung ATE478683T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200510000348A CN100574811C (zh) 2005-01-10 2005-01-10 一种高强度聚焦超声治疗用微粒类助剂及其应用
PCT/CN2005/001392 WO2006072201A1 (fr) 2005-01-10 2005-09-02 Adjuvant sous forme de particules pour un traitement hifu et son utilisation

Publications (1)

Publication Number Publication Date
ATE478683T1 true ATE478683T1 (de) 2010-09-15

Family

ID=36647409

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05781870T ATE478683T1 (de) 2005-01-10 2005-09-02 Teilchenförmiges adjuvans für hifu-therapie und seine verwendung

Country Status (13)

Country Link
US (1) US20080139973A1 (de)
EP (1) EP1842559B1 (de)
JP (1) JP2008526787A (de)
KR (1) KR20070094620A (de)
CN (1) CN100574811C (de)
AT (1) ATE478683T1 (de)
AU (1) AU2005324274B2 (de)
BR (1) BRPI0518497A2 (de)
CA (1) CA2593658C (de)
DE (1) DE602005023217D1 (de)
ES (1) ES2348723T3 (de)
RU (1) RU2360700C2 (de)
WO (1) WO2006072201A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2268361B8 (de) * 2008-04-09 2019-05-22 Julian Itzcovitz Perkutane sonde
US20120259252A1 (en) * 2009-12-22 2012-10-11 Avon Products, Inc. Coupling Emulsions for Use With Ultrasound Devices
AU2012326218B2 (en) 2011-10-17 2017-03-09 Butterfly Network, Inc. Transmissive imaging and related apparatus and methods
DK2846841T3 (en) * 2012-05-09 2017-02-27 Sintef Tto As ULTRASOUND CONTACT FLOW
US9667889B2 (en) 2013-04-03 2017-05-30 Butterfly Network, Inc. Portable electronic devices with integrated imaging capabilities
CN107261197B (zh) * 2017-07-12 2020-05-01 安疗生命科学（武汉）有限公司 一种乳化碘油血管栓塞材料及其制备方法和应用
CN109011228B (zh) * 2018-09-06 2019-08-16 西安交通大学 一种高空间分辨率超声神经调控方法及系统
CN121969423A (zh) * 2023-10-05 2026-05-01 杰希思医疗集团株式会社 皮肤管理装置

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5832829A (ja) * 1981-08-22 1983-02-25 Green Cross Corp:The 血管造影剤
US4767610A (en) * 1984-10-19 1988-08-30 The Regents Of The University Of California Method for detecting abnormal cell masses in animals
US4987154A (en) * 1986-01-14 1991-01-22 Alliance Pharmaceutical Corp. Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use
US6551576B1 (en) * 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US6613306B1 (en) * 1990-04-02 2003-09-02 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US5196183A (en) * 1991-12-04 1993-03-23 Sterling Winthrop Inc. Contrast agents for ultrasound imaging
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
CA2119327A1 (en) * 1993-07-19 1995-01-20 David Crawford Gibbon Method and means for detecting people in image sequences
CN1148812A (zh) * 1994-03-28 1997-04-30 尼科梅德成像有限公司 “脂质体”
US5605934A (en) * 1995-03-23 1997-02-25 Baxter International Inc. Method of manufacturing and storing solutions
US6165442A (en) * 1996-02-19 2000-12-26 Nycomed Imaging As Thermally stabilized ultrasound contrast agent
DE69721235T2 (de) * 1996-02-19 2004-02-05 Amersham Health As Verbesserungen an (oder im bezug auf) kontrastmittel
CN1380106A (zh) * 2001-11-20 2002-11-20 张军 热疗栓塞剂及其使用方法
CN1194763C (zh) * 2002-09-06 2005-03-30 中国人民解放军第三军医大学 新型脂质体超声造影剂及其制备方法

Also Published As

Publication number Publication date
AU2005324274B2 (en) 2008-08-14
RU2007127666A (ru) 2009-01-27
CA2593658A1 (en) 2006-07-13
JP2008526787A (ja) 2008-07-24
US20080139973A1 (en) 2008-06-12
ES2348723T3 (es) 2010-12-13
AU2005324274A1 (en) 2006-07-13
RU2360700C2 (ru) 2009-07-10
KR20070094620A (ko) 2007-09-20
CN100574811C (zh) 2009-12-30
EP1842559A1 (de) 2007-10-10
CN1803198A (zh) 2006-07-19
WO2006072201A1 (fr) 2006-07-13
EP1842559B1 (de) 2010-08-25
BRPI0518497A2 (pt) 2008-11-25
EP1842559A4 (de) 2008-03-19
CA2593658C (en) 2011-06-07
DE602005023217D1 (de) 2010-10-07

Similar Documents

Publication Publication Date Title
DE602005023217D1 (de) Teilchenförmiges adjuvans für hifu-therapie und seine verwendung
JP2005517488A5 (de)
DK1744789T3 (da) Röntgen-stråler og UV aktiverbare partikler, deres fremstilling og deres terapeutiske og diagnostiske brug
CO2018011356A2 (es) Sistemas y metodos para el tratamiento cosmético de ultrasonido de la piel
EP2860192A3 (de) Gewinnung und Profilierung von vollständig humanen, von HuCAL GOLD-abgeleiteten therapeutischen Antikörpern für humanes CD38
DE502005002436D1 (de) Endochirurgischer bergebeutel für die aufnahme von körpergewebe oder -flüssigkeit
EP1355696A4 (de) Ultraschall-wundbehandlungsmethode und vorrichtung unter verwendung stehender wellen
EP2143795A3 (de) Monoklonaler Antikörper gegen CD20
ATE491476T1 (de) Adjuvans von fluorocarbon-emulsionen zur hifu- therapie und verwendung davon
JP2007513610A5 (de)
Jin et al. Transcranial focused ultrasound precise neuromodulation: a review of focal size regulation, treatment efficiency and mechanisms
JP5664996B2 (ja) 超音波照射装置
CN207270576U (zh) 一种用于人体去脂减肥的超声波聚焦治疗探头
NO20045575L (no) Fremstilling av krystallinske materialer ved bruk av ultralyd med stor styrke
CN120137773A (zh) 用于使用超声能量将生物组织解离成单细胞的方法和系统
ATE536843T1 (de) Wärmekissen
US20240399175A1 (en) Reversal of senescence by ultrasound irradiation
Lee et al. Prediction of the size of a thermal lesion in soft tissue during HIFU treatment
He et al. Dual-frequency high intensity focused ultrasound (HIFU) accelerating therapy
James et al. The physical and biological properties of ultrasound and clinical experience
Varol Ultrasound-mediated cancer therapy as a noninvasive and repeatable treatment strategy
Zeng et al. Ultrasound activated bowl-like nanomotors release nitric oxide for enhanced thrombus therapy
JP3070401U (ja) 治療具
CN202022919U (zh) 一种高强度聚焦超声干预细菌生物被膜实验的实验装置
CN203169346U (zh) 一种实验用动物固定装置

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties